As of 2024-12-11, the Fair Value of Innocan Pharma Corp (INNO.CN) is -0.06 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.22 CAD, the upside of Innocan Pharma Corp is -129.87%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -3.33 | -9.95 | -10.05 | -3.76 | -4.70 | -6.36 |
| YoY growth | -179.78% | -198.44% | -0.94% | 62.54% | -24.87% | -68.30% |
| Market Cap (mil) | 61.69 |
| P/E | |
| Forward P/E |
| EPS | -0.01 |
| Avg earnings growth rate | -68.30% |
| TTM earnings | -2.60 |